|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
DK1499348T3
(en)
|
2002-04-26 |
2015-01-05 |
Medimmune Llc |
PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
|
|
CA2514667C
(en)
*
|
2003-01-30 |
2013-01-08 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
US20060110406A1
(en)
|
2003-02-25 |
2006-05-25 |
Medimmune Vaccines, Inc. |
Refrigerator-temperature stable influenza vaccine compositions
|
|
EP2481819A1
(en)
*
|
2003-02-25 |
2012-08-01 |
MedImmune Vaccines, Inc. |
Cross flow filtration in the production of stabilized influenza vaccine compositions
|
|
AU2012201973B2
(en)
*
|
2003-02-25 |
2014-05-22 |
Medimmune, Llc |
Methods of producing influenza vaccine compositions
|
|
TWI350174B
(en)
*
|
2003-03-12 |
2011-10-11 |
Wyeth Corp |
Adjuvanted bovine vaccines
|
|
CA2551489C
(en)
|
2003-12-23 |
2013-09-03 |
Gregory Duke |
Multi plasmid system for the production of influenza virus
|
|
JP5600375B2
(ja)
|
2004-03-09 |
2014-10-01 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
インフルエンザウイルスワクチン
|
|
ATE489965T1
(de)
|
2004-09-09 |
2010-12-15 |
Novartis Vaccines & Diagnostic |
Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
|
|
US20090004222A1
(en)
|
2004-11-03 |
2009-01-01 |
O'hagan Derek |
Influenza Vaccination
|
|
US20090028903A1
(en)
*
|
2005-03-23 |
2009-01-29 |
Glaxosmithkline Biologicals, S.A. |
Novel use
|
|
AR054020A1
(es)
*
|
2005-03-23 |
2007-05-30 |
Glaxosmithkline Biolog Sa |
Nuevo uso
|
|
US11707520B2
(en)
|
2005-11-03 |
2023-07-25 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
JP2009514844A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
|
|
AU2006310338A1
(en)
*
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Adminstration routes for priming/boosting with influenza vaccines
|
|
CA2628152C
(en)
|
2005-11-04 |
2016-02-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
JP5005700B2
(ja)
*
|
2005-11-04 |
2012-08-22 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
アルミニウムアジュバントに即座に吸着されるインフルエンザワクチン
|
|
NZ568212A
(en)
|
2005-11-04 |
2012-03-30 |
Novartis Vaccines & Diagnostic |
Changing Th1/Th2 balance in split influenza vaccines with adjuvants
|
|
NZ594482A
(en)
|
2005-11-04 |
2012-11-30 |
Novartis Vaccines & Diagnostic |
Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant
|
|
NZ568211A
(en)
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
CN102755645A
(zh)
|
2005-11-04 |
2012-10-31 |
诺华疫苗和诊断有限公司 |
佐剂配制的包含细胞因子诱导剂的流感疫苗
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
CN101448523A
(zh)
|
2006-03-24 |
2009-06-03 |
诺华疫苗和诊断有限两合公司 |
无需冷藏储存流感疫苗
|
|
US9072701B2
(en)
*
|
2006-04-21 |
2015-07-07 |
St. Jude Children's Research Hospital |
Avian influenza viruses, vaccines, compositions, formulations, and methods
|
|
PT2054431E
(pt)
|
2006-06-09 |
2011-11-03 |
Novartis Ag |
Confórmeros de adesinas bacterianas
|
|
WO2007144772A2
(en)
*
|
2006-06-15 |
2007-12-21 |
Novartis Ag |
Adjuvant-sparing multi-dose influenza vaccination regimen
|
|
US20080014217A1
(en)
*
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
PT2422810E
(pt)
*
|
2006-07-17 |
2014-12-03 |
Glaxosmithkline Biolog Sa |
Vacina da gripe
|
|
CA2583555C
(en)
*
|
2006-07-17 |
2020-01-07 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine
|
|
MX2009000660A
(es)
*
|
2006-07-17 |
2009-04-08 |
Glaxosmithkline Biolog Sa |
Vacuna de influenza.
|
|
GB0614460D0
(en)
*
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
EP4585610A3
(en)
|
2006-09-11 |
2025-09-24 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
EA015817B1
(ru)
|
2006-10-12 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
|
|
GB0622282D0
(en)
|
2006-11-08 |
2006-12-20 |
Novartis Ag |
Quality control methods
|
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
|
CN101085348B
(zh)
*
|
2007-06-18 |
2010-08-18 |
南京农业大学 |
用于禽流感灭活抗原的鼻腔免疫复合佐剂
|
|
EP2674486A1
(en)
|
2007-06-18 |
2013-12-18 |
MedImmune, LLC |
Influenza B viruses having alterations in the hemaglutinin polypeptide
|
|
KR20100045437A
(ko)
|
2007-06-27 |
2010-05-03 |
노파르티스 아게 |
첨가물이 적은 인플루엔자 백신
|
|
US20090098143A1
(en)
*
|
2007-06-29 |
2009-04-16 |
Avianax, Inc. |
Vaccine production for pathogenic bird viral diseases
|
|
WO2009014919A2
(en)
*
|
2007-07-13 |
2009-01-29 |
Iowa State University Research Foundation, Inc. |
H2n3 influenza a viruses and methods of use
|
|
CN106310293A
(zh)
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
GB0810305D0
(en)
*
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
JP2011506290A
(ja)
|
2007-12-06 |
2011-03-03 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
インフルエンザ組成物
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
AU2008339631B2
(en)
|
2007-12-24 |
2014-07-24 |
Novartis Ag |
Assays for adsorbed influenza vaccines
|
|
US20120034266A1
(en)
*
|
2008-03-04 |
2012-02-09 |
Nel Andre E |
Methods and compositions for improving immune response by a nutraceutical antioxidant
|
|
CN101959527B
(zh)
|
2008-03-05 |
2016-04-20 |
赛诺菲巴斯德有限公司 |
一种使含佐剂的疫苗组合物稳定的方法
|
|
JP5518041B2
(ja)
*
|
2008-03-18 |
2014-06-11 |
ノバルティス アーゲー |
インフルエンザウイルスワクチン抗原の調製における改良
|
|
EP2278997B1
(en)
*
|
2008-04-21 |
2016-08-10 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
|
WO2009146523A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
EP2310045A1
(en)
|
2008-06-25 |
2011-04-20 |
Novartis AG |
Rapid responses to delayed booster immunisations
|
|
US20110150926A1
(en)
|
2008-08-01 |
2011-06-23 |
Mohammed Alsharifi |
Influenza vaccines
|
|
RU2400536C1
(ru)
*
|
2009-01-11 |
2010-09-27 |
Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУП ГНЦ ВБ "Вектор" Роспотребнадзора) |
ШТАММ ВИРУСА ГРИППА ПТИЦ A/common gull/Chany/2006 H5N1 СУБТИПА ДЛЯ ПРИГОТОВЛЕНИЯ АНТИГЕНСОДЕРЖАЩЕГО ДИАГНОСТИЧЕСКОГО ИЛИ ВАКЦИННОГО ПРЕПАРАТА
|
|
EP3173097A3
(en)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
EP2411048B1
(en)
|
2009-03-24 |
2020-05-06 |
GlaxoSmithKline Biologicals SA |
Adjuvanting meningococcal factor h binding protein
|
|
USH2283H1
(en)
|
2009-04-27 |
2013-09-03 |
Novartis Ag |
Vaccines for protecting against influenza
|
|
NZ596671A
(en)
|
2009-05-29 |
2013-06-28 |
Novartis Ag |
Assays for influenza virus hemagglutinins
|
|
US20120237536A1
(en)
|
2009-09-10 |
2012-09-20 |
Novartis |
Combination vaccines against respiratory tract diseases
|
|
JP5774010B2
(ja)
*
|
2009-09-25 |
2015-09-02 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
インフルエンザウイルスのための免疫拡散アッセイ
|
|
MX2012004067A
(es)
|
2009-10-09 |
2012-08-03 |
Cbio Ltd |
Variantes de la chaperonina 10.
|
|
RS52565B
(sr)
|
2009-12-03 |
2013-04-30 |
Novartis Ag |
Metod interakcije i komore sa povratnim pritiskom za mikrofluidizaciju
|
|
DE102009056871A1
(de)
|
2009-12-03 |
2011-06-22 |
Novartis AG, 4056 |
Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
|
|
CL2012001399A1
(es)
|
2009-12-03 |
2013-03-08 |
Novartis Ag |
Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
|
|
CN104688687A
(zh)
|
2009-12-03 |
2015-06-10 |
诺华股份有限公司 |
疫苗佐剂制备中的亲水过滤
|
|
DE102009056884B4
(de)
|
2009-12-03 |
2021-03-18 |
Novartis Ag |
Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
|
|
DE102009056883B4
(de)
|
2009-12-03 |
2012-08-16 |
Novartis Ag |
Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
|
|
EP2506834B1
(en)
|
2009-12-03 |
2016-03-02 |
Novartis AG |
Circulation of components during homogenization and microfluidization of emulsions
|
|
NZ603918A
(en)
|
2010-05-12 |
2015-04-24 |
Novartis Ag |
Improved methods for preparing squalene
|
|
AU2011300402B2
(en)
|
2010-09-07 |
2015-01-22 |
Novartis Ag |
Generic assays for detection of mammalian reovirus
|
|
US9821051B1
(en)
|
2010-10-28 |
2017-11-21 |
Seqirus UK Limited |
Reducing hospitalization in elderly influenza vaccine recipients
|
|
EP2667891B1
(en)
|
2011-01-27 |
2021-10-06 |
Gamma Vaccines Pty Limited |
Combination vaccines
|
|
CN113876945A
(zh)
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
WO2013088367A1
(en)
|
2011-12-12 |
2013-06-20 |
Novartis Ag |
Assay for influenza virus hemagglutinins
|
|
JP2015505309A
(ja)
|
2011-12-29 |
2015-02-19 |
ノバルティス アーゲー |
髄膜炎菌ｈ因子結合タンパク質のアジュバントされた組み合わせ
|
|
CA2868120C
(en)
|
2012-03-23 |
2019-02-19 |
Pitney Pharmaceuticals Pty Limited |
Kinase inhibitors for the treatment of cancer
|
|
EP3530283A1
(en)
|
2012-06-05 |
2019-08-28 |
The Australian National University |
Vaccination with interleukin-4 antagonists
|
|
US9982240B2
(en)
|
2012-08-03 |
2018-05-29 |
Sanofi Pasteur |
Production of infectious influenza viruses
|
|
EP2880014B1
(en)
|
2012-08-06 |
2017-05-17 |
Pitney Pharmaceuticals Pty Limited |
Compounds for the treatment of mtor pathway related diseases
|
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
|
WO2014094041A1
(en)
|
2012-12-17 |
2014-06-26 |
Pitney Pharmaceuticals Pty Limited |
Treatment of diseases involving mucin
|
|
US10357538B2
(en)
|
2012-12-24 |
2019-07-23 |
Northern Sydney Local Health District |
Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
|
|
RU2523614C1
(ru)
*
|
2013-04-09 |
2014-07-20 |
Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации |
Вакцина против гриппа и способ ее получения
|
|
US10364277B2
(en)
|
2013-07-01 |
2019-07-30 |
Newsouth Innovations Pty Limited |
Diagnosis and treatment of autoimmune diseases
|
|
US10286062B2
(en)
*
|
2013-07-09 |
2019-05-14 |
Texas Tech University System |
Universal influenza vaccine
|
|
KR20160036669A
(ko)
*
|
2013-07-31 |
2016-04-04 |
주식회사 쿠라레 |
투명성, 열 균열 현상 억제가 우수한 폴리비닐 아세탈 필름
|
|
US10238739B2
(en)
|
2014-12-02 |
2019-03-26 |
Novartis Ag |
Manufacture of surfactant-containing compositions with enhanced stability
|
|
MY191539A
(en)
|
2015-03-26 |
2022-06-30 |
Gpn Vaccines Pty Ltd |
Streptococcal vaccine
|
|
US11013795B2
(en)
|
2015-06-26 |
2021-05-25 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
|
KR102790570B1
(ko)
|
2015-07-07 |
2025-04-04 |
세퀴러스 유케이 리미티드 |
인플루엔자 효능 검정
|
|
CN105251002B
(zh)
*
|
2015-11-13 |
2019-02-15 |
中国人民解放军第三军医大学 |
一种水包油型纳米乳佐剂及其mrsa纳米乳佐剂疫苗和制备方法
|
|
US12128102B2
(en)
|
2016-03-08 |
2024-10-29 |
Takeda Pharmaceutical Company Limited |
Constrained conditionally activated binding proteins
|
|
KR20260047644A
(ko)
|
2017-03-30 |
2026-04-08 |
더 유니버서티 어브 퀸슬랜드 |
키메라 분자 및 그의 용도
|
|
CN111356700A
(zh)
|
2017-09-08 |
2020-06-30 |
马弗里克治疗公司 |
受约束的条件性活化的结合蛋白
|
|
ES2991988T3
(es)
|
2017-10-30 |
2024-12-05 |
Takeda Pharmaceuticals Co |
Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
|
|
FI20215508A1
(en)
|
2020-04-09 |
2021-10-10 |
Niemelae Erik Johan |
Mimetic nanoparticles to prevent the spread of new coronaviruses and reduce the rate of infection
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
AU2021302954A1
(en)
|
2020-06-30 |
2023-02-16 |
Seqirus UK Limited |
Cold filtration of oil-in-water emulsion adjuvants
|
|
CN111803625B
(zh)
*
|
2020-09-09 |
2020-12-18 |
天津中逸安健生物科技有限公司 |
一种亚单位流感疫苗裂解剂及其应用
|
|
WO2025019631A1
(en)
|
2023-07-19 |
2025-01-23 |
Icahn School Of Medicine At Mount Sinai |
Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
|